CLINICAL OUTCOMES EverFlex Peripheral Self-expanding Stent System

DURABILITY II is the first controlled study to focus on treating long, complex lesions and to specifically test the performance of a single long stent in the superficial femoral artery. Read more about the DURABILITY II clinical study in these published, peer-reviewed journal articles.

DURABILITY II — Gender 3-Year

Intermediate Outcomes of Femoropopliteal Stenting in Women: 3-Year Results of the DURABILITY II Trial.

Han DK, et al. Ann Vasc Surg. 2016;30:110-117.

DURABILITY 200 — Long Lesions

Results of the Protégé EverFlex 200-mm-long Nitinol Stent (ev3) in TASC C and D Femoropopliteal Lesions.

Bosiers M, et al. J Vasc Surg. 2011;54:1042-1050.

Peripheral Catalog

Choose from a full portfolio of peripheral products for endovascular interventions — products that help you reach your PAD patient treatment goals.

Download Catalog

Request More Information

Connect with Us

Contact Us

CardioVascular Lifeline Customer Support

Toll-free 1-877-526-7890


Toll-free 1-800-716-6700

24-hour Technical Support

1-763-514-4000 (Worldwide)
Toll-free 1-800-328-2518